Telomeres and Telomerase
Cell-culture studies have reported changes in telomerase activity and telomere length. These findings do not demonstrate that Epitalon reverses aging or extends human life.
Explore cellular-aging research and individualized guidance for your long-term health goals.
Book Your Appointment
Epitalon, also spelled Epithalon, is a synthetic four-amino-acid peptide explored in cellular-aging research. Researchers developed it from work on epithalamin, a pineal-gland extract. However, the two are different substances.
Science worth understanding: Epitalon remains under study and has no FDA approval. Interest in its biology has grown, but studies have not established meaningful benefits or long-term safety in people.
Its appeal comes from questions about how cells age and communicate. These are research areas, rather than proven treatment benefits.


Cell-culture studies have reported changes in telomerase activity and telomere length. These findings do not demonstrate that Epitalon reverses aging or extends human life.
Pineal-peptide research has explored melatonin rhythms. However, findings about other peptides or extracts do not automatically apply to Epitalon.
Laboratory studies examine gene expression, chromatin activity, and cellular responses. It is still unclear what these findings mean for patient care.
A change in a cellular marker is not the same as better health, fewer illnesses, or longer life. Clinical outcomes require studies in people.
Telomeres help protect chromosome ends. However, their biology is complex. Longer telomeres are not automatically better, and telomerase activity alone does not measure healthy aging.


Research in cultured cells—including cancer cell lines—helps generate scientific questions. It does not establish an anti-aging treatment or prove that Epitalon causes or prevents cancer. Potential effects on abnormal cell growth remain an important safety question.
Both appear in telomerase discussions, but they are not interchangeable.


Sellers market TA-65 as a dietary supplement derived from Astragalus. Supplement marketing does not establish that a product treats disease or extends lifespan.
Epitalon is a synthetic peptide under investigation. Evidence about an oral supplement cannot validate the safety, effectiveness, or absorption of a peptide preparation.
The product image helps explain this comparison. It does not endorse or recommend the product.
Bring your questions about sleep, recovery, and healthy aging. Our Pasadena team can help you understand the research while focusing on practical steps for your health.


First, discuss symptoms, health history, medications, supplements, and what you hope to improve.
Next, explore suitable evaluation and established care options. A research discussion does not require committing to a peptide treatment.
Different delivery methods do not resolve gaps in evidence. Research has not established clinical dosing, interactions, or long-term safety.


Injection, oral, and nasal products may differ. Absorption and product quality can differ, and injection adds contamination and local-reaction risks.
Pairing Epitalon with DSIP or other longevity-focused compounds does not establish additional benefit. Combination safety and interactions need evidence of their own.
FDA has highlighted concerns about aggregation, peptide impurities, and possible immune reactions, with limited safety information for proposed administration routes.
Discuss cancer history, pregnancy or breastfeeding, and all medications with your clinician. A lack of reported adverse effects does not establish safety.
Clear information about the substance, evidence, and regulatory status matters as much as the source.
FDA compounding advisory review is separate from drug approval. A nomination or committee recommendation does not itself establish final list inclusion or availability.
Any prescribing or compounding must satisfy current requirements. A licensed pharmacy or purity certificate does not establish clinical effectiveness or permission to compound a particular substance.
Compounded drugs are not FDA-approved. This page does not promise access to Epitalon or a future availability date.
Straightforward answers to common research and consultation questions.


No. Epitalon is a synthetic tetrapeptide; epithalamin is a pineal-gland extract containing multiple peptides. For this reason, results for one do not automatically apply to the other.
Research has not established benefits in people. Laboratory findings about telomeres do not demonstrate longer life or improved health in people.
Research has explored pineal peptides and daily rhythms, but Epitalon is not an established insomnia treatment. Persistent sleep difficulties deserve an individualized evaluation.
It raises a biological question, not a confirmed clinical outcome. Long-term human data are insufficient to establish the risk; tell your clinician about any cancer history.
No validated clinical regimen exists. Claims about injections, capsules, or nasal products do not amount to approved treatment instructions.
There is no established safety or effectiveness for these combinations. Review all products with your provider rather than following an online stack protocol.
We review your health concerns, explain the evidence, and discuss appropriate care options. A visit does not guarantee an Epitalon prescription.
Eligibility depends on the service, medical necessity, and plan rules. Before paying, confirm which expenses your plan or account covers.
Meet with our medical team to discuss your goals and identify a practical next step.
Book Your AppointmentThis page is educational and does not replace medical advice. Epitalon is investigational and not FDA-approved. Human benefits and long-term safety remain uncertain; consultation does not establish treatment availability.
These sources include regulatory evaluations and laboratory or exploratory research. Consider each source in light of its study design.